# RELAFEN
> **NDA019583** · New Drug Application · Sponsor: SMITHKLINE BEECHAM · Approved 1991-12-24
## Drug
- **FDA Application Number:** NDA019583
- **Application type:** New Drug Application
- **Brand name:** RELAFEN
- **Generic name:** Nabumetone
- **Active ingredients:** NABUMETONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SMITHKLINE BEECHAM
- **First approval:** 1991-12-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019583)
---
*AI Analytics · CC0 1.0*